# Intuit Inc.: financial statements, quarterly

INTU · Nasdaq · CIK 896878 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/intu.md) · [Financials](/companies/intu/financials.md) · [Filings](/companies/intu/filings.md) · [Insiders](/companies/intu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/intu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,978](/filings/0000896878-24-000053.md) | [3,386](/filings/0000896878-25-000015.md) | [6,737](/filings/0000896878-25-000022.md) | [3,184 d](/filings/0000896878-26-000037.md) | [3,283](/filings/0000896878-25-000048.md) | [3,963](/filings/0000896878-26-000014.md) | [7,754](/filings/0000896878-26-000025.md) | [3,831 d](/filings/0000896878-26-000037.md) | [3,885](/filings/0000896878-25-000048.md) | [4,651](/filings/0000896878-26-000014.md) | [8,558](/filings/0000896878-26-000025.md) | [4,354 d](/filings/0000896878-26-000037.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [680](/filings/0000896878-24-000053.md) | [678](/filings/0000896878-25-000015.md) | [671](/filings/0000896878-25-000022.md) | [725 d](/filings/0000896878-26-000037.md) | [704](/filings/0000896878-25-000048.md) | [716](/filings/0000896878-26-000014.md) | [707](/filings/0000896878-26-000025.md) | [801 d](/filings/0000896878-26-000037.md) | [843](/filings/0000896878-25-000048.md) | [836](/filings/0000896878-26-000014.md) | [840](/filings/0000896878-26-000025.md) | [857 d](/filings/0000896878-26-000037.md) |
| Operating income | $m | [307](/filings/0000896878-24-000053.md) | [369](/filings/0000896878-25-000015.md) | [3,105](/filings/0000896878-25-000022.md) | [(151) d](/filings/0000896878-26-000037.md) | [271](/filings/0000896878-25-000048.md) | [593](/filings/0000896878-26-000014.md) | [3,720](/filings/0000896878-26-000025.md) | [339 d](/filings/0000896878-26-000037.md) | [534](/filings/0000896878-25-000048.md) | [855](/filings/0000896878-26-000014.md) | [4,020](/filings/0000896878-26-000025.md) | [475 d](/filings/0000896878-26-000037.md) |
| Income tax | $m | [23.0](/filings/0000896878-24-000053.md) | [1.0](/filings/0000896878-25-000015.md) | [683](/filings/0000896878-25-000022.md) | [(120) d](/filings/0000896878-26-000037.md) | [16.0](/filings/0000896878-25-000048.md) | [100](/filings/0000896878-26-000014.md) | [864](/filings/0000896878-26-000025.md) | [(15.0) d](/filings/0000896878-26-000037.md) | [115](/filings/0000896878-25-000048.md) | [176](/filings/0000896878-26-000014.md) | [983](/filings/0000896878-26-000025.md) | [177 d](/filings/0000896878-26-000037.md) |
| Net income | $m | [241](/filings/0000896878-24-000053.md) | [353](/filings/0000896878-25-000015.md) | [2,389](/filings/0000896878-25-000022.md) | [(20.0) d](/filings/0000896878-26-000037.md) | [197](/filings/0000896878-25-000048.md) | [471](/filings/0000896878-26-000014.md) | [2,820](/filings/0000896878-26-000025.md) | [381 d](/filings/0000896878-26-000037.md) | [446](/filings/0000896878-25-000048.md) | [693](/filings/0000896878-26-000014.md) | [3,064](/filings/0000896878-26-000025.md) | [363 d](/filings/0000896878-26-000037.md) |
| Diluted EPS | $ per share | [0.85](/filings/0000896878-24-000053.md) | [1.25](/filings/0000896878-25-000015.md) | [8.42](/filings/0000896878-25-000022.md) | not reported | [0.70](/filings/0000896878-25-000048.md) | [1.67](/filings/0000896878-26-000014.md) | [10.02](/filings/0000896878-26-000025.md) | not reported | [1.59](/filings/0000896878-25-000048.md) | [2.48](/filings/0000896878-26-000014.md) | [11.09](/filings/0000896878-26-000025.md) | not reported |
| Basic EPS | $ per share | [0.86](/filings/0000896878-24-000053.md) | [1.26](/filings/0000896878-25-000015.md) | [8.53](/filings/0000896878-25-000022.md) | not reported | [0.70](/filings/0000896878-25-000048.md) | [1.68](/filings/0000896878-26-000014.md) | [10.09](/filings/0000896878-26-000025.md) | not reported | [1.60](/filings/0000896878-25-000048.md) | [2.49](/filings/0000896878-26-000014.md) | [11.10](/filings/0000896878-26-000025.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.7](/filings/0000896878-24-000053.md) | [1.5](/filings/0000896878-25-000015.md) | [4.2](/filings/0000896878-25-000022.md) | [3.6](/filings/0000896878-26-000037.md) | [2.9](/filings/0000896878-25-000048.md) | [2.4](/filings/0000896878-26-000014.md) | [5.4](/filings/0000896878-26-000025.md) | [2.9](/filings/0000896878-26-000037.md) | [3.5](/filings/0000896878-25-000048.md) | [2.9](/filings/0000896878-26-000014.md) | [4.7](/filings/0000896878-26-000025.md) | [4.7](/filings/0000896878-26-000037.md) |
| Current assets | $bn | [6.2](/filings/0000896878-23-000041.md) | [7.3](/filings/0000896878-24-000011.md) | [9.2](/filings/0000896878-24-000026.md) | [9.7](/filings/0000896878-25-000035.md) | [10.7](/filings/0000896878-24-000053.md) | [9.1](/filings/0000896878-25-000015.md) | [14.0](/filings/0000896878-25-000022.md) | [14.1](/filings/0000896878-26-000037.md) | [10.4](/filings/0000896878-25-000048.md) | [11.7](/filings/0000896878-26-000014.md) | [17.8](/filings/0000896878-26-000025.md) | [15.3](/filings/0000896878-26-000037.md) |
| Total assets | $bn | [28.5](/filings/0000896878-23-000041.md) | [29.7](/filings/0000896878-24-000011.md) | [31.6](/filings/0000896878-24-000026.md) | [32.1](/filings/0000896878-25-000035.md) | [33.2](/filings/0000896878-24-000053.md) | [31.7](/filings/0000896878-25-000015.md) | [36.6](/filings/0000896878-25-000022.md) | [37.0](/filings/0000896878-26-000037.md) | [33.2](/filings/0000896878-25-000048.md) | [34.3](/filings/0000896878-26-000014.md) | [39.3](/filings/0000896878-26-000025.md) | [36.8](/filings/0000896878-26-000037.md) |
| Current liabilities | $bn | [5.0](/filings/0000896878-23-000041.md) | [6.2](/filings/0000896878-24-000011.md) | [6.2](/filings/0000896878-24-000026.md) | [7.5](/filings/0000896878-25-000035.md) | [8.6](/filings/0000896878-24-000053.md) | [7.2](/filings/0000896878-25-000015.md) | [9.7](/filings/0000896878-25-000022.md) | [10.4](/filings/0000896878-26-000037.md) | [7.5](/filings/0000896878-25-000048.md) | [8.8](/filings/0000896878-26-000014.md) | [12.3](/filings/0000896878-26-000025.md) | [10.2](/filings/0000896878-26-000037.md) |
| Total liabilities | $bn | [11.5](/filings/0000896878-23-000041.md) | [12.8](/filings/0000896878-24-000011.md) | [12.8](/filings/0000896878-24-000026.md) | [13.7](/filings/0000896878-25-000035.md) | [15.1](/filings/0000896878-24-000053.md) | [13.7](/filings/0000896878-25-000015.md) | [16.5](/filings/0000896878-25-000022.md) | [17.2](/filings/0000896878-26-000037.md) | [13.9](/filings/0000896878-25-000048.md) | [15.2](/filings/0000896878-26-000014.md) | [18.7](/filings/0000896878-26-000025.md) | [17.8](/filings/0000896878-26-000037.md) |
| Long-term debt | $bn | [5.9](/filings/0000896878-23-000041.md) | [6.0](/filings/0000896878-24-000011.md) | [6.0](/filings/0000896878-24-000026.md) | [5.5](/filings/0000896878-25-000035.md) | [5.6](/filings/0000896878-24-000053.md) | [5.8](/filings/0000896878-25-000015.md) | [5.9](/filings/0000896878-25-000022.md) | [6.0](/filings/0000896878-26-000037.md) | [5.4](/filings/0000896878-25-000048.md) | [5.4](/filings/0000896878-26-000014.md) | [5.4](/filings/0000896878-26-000025.md) | [6.4](/filings/0000896878-26-000037.md) |
| Current portion of debt | $bn | [0.0](/filings/0000896878-23-000041.md) | [0.0](/filings/0000896878-24-000011.md) | [0.0](/filings/0000896878-24-000026.md) | [0.5](/filings/0000896878-25-000035.md) | [0.5](/filings/0000896878-24-000053.md) | [0.5](/filings/0000896878-25-000015.md) | [0.5](/filings/0000896878-25-000022.md) | [0.0](/filings/0000896878-26-000037.md) | [0.7](/filings/0000896878-25-000048.md) | [0.7](/filings/0000896878-26-000014.md) | [0.8](/filings/0000896878-26-000025.md) | [1.2](/filings/0000896878-26-000037.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [17.0](/filings/0000896878-25-000015.md) | [16.9](/filings/0000896878-25-000022.md) | [18.8](/filings/0000896878-25-000022.md) | [18.4](/filings/0000896878-26-000037.md) | [18.1](/filings/0000896878-26-000014.md) | [17.9](/filings/0000896878-26-000025.md) | [20.1](/filings/0000896878-26-000025.md) | [19.7](/filings/0000896878-26-000037.md) | [19.3](/filings/0000896878-26-000014.md) | [19.1](/filings/0000896878-26-000025.md) | [20.6](/filings/0000896878-26-000025.md) | [19.0](/filings/0000896878-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(97.0)](/filings/0000896878-24-000053.md) | [613 d](/filings/0000896878-25-000015.md) | [3,951 d](/filings/0000896878-25-000022.md) | [417 d](/filings/0000896878-26-000037.md) | [362](/filings/0000896878-25-000048.md) | [1,069 d](/filings/0000896878-26-000014.md) | [4,395 d](/filings/0000896878-26-000025.md) | [381 d](/filings/0000896878-26-000037.md) | [637](/filings/0000896878-25-000048.md) | [1,570 d](/filings/0000896878-26-000014.md) | [5,300 d](/filings/0000896878-26-000025.md) | [1,331 d](/filings/0000896878-26-000037.md) |
| Capital expenditure | $m | [84.0](/filings/0000896878-24-000053.md) | [63.0 d](/filings/0000896878-25-000015.md) | [61.0 d](/filings/0000896878-25-000022.md) | [(17.0) d](/filings/0000896878-26-000037.md) | [33.0](/filings/0000896878-25-000048.md) | [31.0 d](/filings/0000896878-26-000014.md) | [35.0 d](/filings/0000896878-26-000025.md) | [(15.0) d](/filings/0000896878-26-000037.md) | [38.0](/filings/0000896878-25-000048.md) | [46.0 d](/filings/0000896878-26-000014.md) | [64.0 d](/filings/0000896878-26-000025.md) | [27.0 d](/filings/0000896878-26-000037.md) |
| Dividends paid | $m | [260](/filings/0000896878-24-000053.md) | [256 d](/filings/0000896878-25-000015.md) | [257 d](/filings/0000896878-25-000022.md) | [261 d](/filings/0000896878-26-000037.md) | [296](/filings/0000896878-25-000048.md) | [300 d](/filings/0000896878-26-000014.md) | [292 d](/filings/0000896878-26-000025.md) | [301 d](/filings/0000896878-26-000037.md) | [341](/filings/0000896878-25-000048.md) | [341 d](/filings/0000896878-26-000014.md) | [333 d](/filings/0000896878-26-000025.md) | [332 d](/filings/0000896878-26-000037.md) |
| Share repurchases | $m | [584](/filings/0000896878-24-000053.md) | [551 d](/filings/0000896878-25-000015.md) | [572 d](/filings/0000896878-25-000022.md) | [281 d](/filings/0000896878-26-000037.md) | [557](/filings/0000896878-25-000048.md) | [717 d](/filings/0000896878-26-000014.md) | [752 d](/filings/0000896878-26-000025.md) | [746 d](/filings/0000896878-26-000037.md) | [854](/filings/0000896878-25-000048.md) | [933 d](/filings/0000896878-26-000014.md) | [1,554 d](/filings/0000896878-26-000025.md) | [2,071 d](/filings/0000896878-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [284](/filings/0000896878-23-000041.md) | [282](/filings/0000896878-24-000011.md) | [283](/filings/0000896878-24-000026.md) | [283](/filings/0000896878-24-000053.md) | [284](/filings/0000896878-25-000015.md) | [284](/filings/0000896878-25-000022.md) | [283](/filings/0000896878-25-000048.md) | [283](/filings/0000896878-26-000014.md) | [282](/filings/0000896878-26-000025.md) | [281](/filings/0000896878-25-000048.md) | [280](/filings/0000896878-26-000014.md) | [276](/filings/0000896878-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 267,236,000 at 2026-08-31, from the cover of the [10-K filed 2026-09-09](/filings/0000896878-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.